XLO Latest Press Releases

-- September 28, 2026 --

Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer Globe Newswire 7:30 AM

-- September 2, 2026 --

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- August 12, 2026 --

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates Globe Newswire 7:30 AM

-- July 6, 2026 --

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- June 29, 2026 --

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer Globe Newswire 7:30 AM

-- May 12, 2026 --

Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates Globe Newswire 7:30 AM

-- May 7, 2026 --

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software